OncoMatch/Clinical Trials/NCT06861088
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Is NCT06861088 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies Kinisoquin™ for venous thromboembolism.
Treatment: Kinisoquin™ — The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.
Check if I qualifyExtracted eligibility criteria
Cancer type
Pancreatic Cancer
Disease stage
Required: Stage IV, III
metastatic (including recurrent with distant metastases) or locally advanced
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Must have received: chemotherapy — first line
Receiving first line chemotherapy (within 45 days of first dose of study drug) Note: subjects must be either initiating first systemic cancer therapy regimen following initial diagnosis or initiating first cycle of chemotherapy for disease recurrence.
Lab requirements
Blood counts
Platelet count ≥ 100,000/mcL; PT and PTT ≤ 1.5x institutional ULN
Kidney function
Estimated creatinine clearance (CrCl > 30 mL/min)
Liver function
Total bilirubin ≤ 3x ULN without liver metastases and < 5x ULN in presence of liver metastases; AST and ALT ≤ 3x ULN without liver metastases and < 5x ULN in the presence of liver metastases
Participants must have preserved organ and marrow function as defined by: Platelet count ≥ 100,000/mcL. PT and PTT ≤ 1.5x institutional ULN. Total bilirubin ≤ 3x ULN without liver metastases and < 5x ULN in presence of liver metastases. AST and ALT ≤ 3x ULN without liver metastases and < 5x ULN in the presence of liver metastases. Estimated creatinine clearance (CrCl > 30 mL/min).
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Ventura Clinical Trials · Ventura, California
- Clavis Medical, LLC · Miami Lakes, Florida
- Beth Israel Deaconess Medical Center · Boston, Massachusetts
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify